September 13, 2023 Meeting Of The Cardiovascular And Renal Drugs Advisory Committee

September 13, 2023 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

U.S. Food and Drug Administration

December 13, 2022 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

U.S. Food and Drug Administration

Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

U.S. Food and Drug Administration

October 26, 2022 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

U.S. Food and Drug Administration

November 16, 2022 Meeting of the Cardiovascular and Renal Drugs Advisory Committee

U.S. Food and Drug Administration

July 15, 2021 Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting

U.S. Food and Drug Administration

September 21, 2023 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

U.S. Food and Drug Administration

March 16, 2023 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

U.S. Food and Drug Administration

September 11-12, 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) - Day 2

U.S. Food and Drug Administration

May 11, 2023 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

U.S. Food and Drug Administration

Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

February 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

September 11-12, 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) - Day 1

U.S. Food and Drug Administration

April 28, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 2

U.S. Food and Drug Administration

June 9, 2023 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

U.S. Food and Drug Administration

Oncologic Drugs Advisory Committee Meeting

U.S. Food and Drug Administration

March 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration